Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7177198
Reference Type
Journal Article
Title
Synthesis, anti-inflammatory evaluation and in silico studies of naphtho[1,2-e][1,3]oxazine derivatives as potential non-steroidal anti-inflammatory agents
Author(s)
Chanu, LV; Nongalleima, K; Singh, SP; Chanu, WK; Singh, CB; Singh, OM; ,
Year
2020
Is Peer Reviewed?
1
Journal
Medicinal Chemistry Research
ISSN:
1054-2523
EISSN:
1554-8120
Publisher
SPRINGER BIRKHAUSER
Location
NEW YORK
Page Numbers
229-242
DOI
10.1007/s00044-019-02477-4
Web of Science Id
WOS:000511666600007
Abstract
A small molecule library of trans-1,3-diaryl-1H-naphtho[1,2-e][1,3]oxazines 4 is synthesised through multicomponent reactions involving aliphatic amines, aromatic aldehydes and beta-naphthol using a heterogeneous catalyst, SiO2.HClO4, and ethanol as the solvent. The anti-inflammatory activities of the synthesised compounds are evaluated together with in silico studies. 1,3-Bis(4-chlorophenyl)-2-ethyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine (4h) shows the best activity with IC50 = 4.807 mu g/mL in the heat-induced haemolysis, while 1,3-Bis(5-bromothiophen-2-yl)-2-ethyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine (4c) shows significantly high anti-inflammatory activity (IC50 = 5.5 mu g/mL) in comparison with standard drugs, such as sodium diclofenac. In addition, molecular docking simulation study confirms the in-depth molecular interaction of the two lead compounds, 4c and 4h with better binding affinities and docking scores at the active site of the COX-2 enzyme compared with diclofenac.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity